Vijitha S Vempuluru Selected Research

Vijitha S Vempuluru Research Topics

7	Neoplasms (Cancer) 01/2022 - 11/2020
3	Retinoblastoma (Glioblastoma, Retinal) 10/2023 - 07/2020
2	Xeroderma Pigmentosum (Kaposi's Disease) 01/2022 - 11/2021
2	Neoplasm Metastasis (Metastasis) 07/2021 - 07/2020
1	Scleritis (Episcleritis) 11/2023
1	Asthma (Bronchial Asthma) 09/2023
1	Alkaptonuric ochronosis 09/2023
1	Immunoglobulin G4-Related Disease 09/2023
1	Infections 01/2022
1	Ichthyosis (Xeroderma) 11/2021
1	Cysts 01/2021
1	Phyllodes Tumor (Cystosarcoma Phylloides) 01/2021
1	Canaliculitis 01/2021
1	Melanoma (Melanoma, Malignant) 07/2020
1	Hemangioblastoma 07/2020
1	Primitive Neuroectodermal Tumors (PNET) 07/2020
1	Neurilemmoma (Schwannoma) 07/2020
1	Hemangioma (Angioma) 02/2020

1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 09/2023
1	PolyphenolsIBA 09/2023
1	Homogentisic AcidIBA 09/2023
1	Rituximab (Mabthera)FDA Link 09/2023
1	AntioxidantsIBA 09/2023
1	Keratins (Keratin)IBA 01/2022
1	SteroidsIBA 01/2022
1	Interferon alpha-2 (Roferon-A)FDA Link 02/2021
1	CollagenIBA 01/2021
1	ElementsIBA 01/2021
1	LipofuscinIBA 11/2020
1	Retinaldehyde (Retinal)IBA 07/2020
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 02/2020

2	Drug Therapy (Chemotherapy) 10/2023 - 06/2021
1	Therapeutics 11/2023
1	Telescopes 01/2022
1	Brachytherapy 11/2021
1	Corneal Transplantation (Keratoplasty) 11/2021
1	Aftercare (After-Treatment) 07/2021
1	Duration of Therapy 06/2021
1	Injections 02/2021
1	Curettage 01/2021